The U.S. saw a jump in coronavirus cases and deaths over the last week, according to a memo from the U.S. Department of Health and Human Services obtained by ABC News.

From Nov. 2-8, 730,925 new cases were confirmed, representing a 29.2% increase from the previous seven-day period, according to the memo. During that same time period, there were 6,654 deaths, which represented a 15.1% increase from the previous week, HHS said.

The national test-positivity rate increased to 8.6% from 7.2% in week-to-week comparisons, and 24% of hospitals across the country have more than 80% of their ICU beds filled, the memo said.

-ABC News' Josh Margolin

The Centers for Disease Control is advising Americans to keep their Thanksgiving plans small in updated guidance on its website.

"The safest way to celebrate Thanksgiving this year is to celebrate with people in your household. If you do plan to spend Thanksgiving with people outside your household, take steps to make your celebration safer," the agency said.

The CDC also provided more specific guidance for households over the holiday.

Guests should consider bringing their own food, drinks, plates, cups, and utensils, and avoid going into places where food is prepared, according to the agency.

Hosts should make sure their home is sanitized and consider having the windows open if they are eating indoors, the CDC said.

"If sharing food, have one person serve food and use single-use options, like plastic utensils," the agency said.

-ABC News' Stephanie Ebbs

The FDA has issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild to moderate COVID-19 in adult and pediatric patients.

The treatment, from Eli Lilly and Company, was shown in trials to reduce hospitalization for patients who are at high risk for disease progression within 28 days after treatment when compared to placebo, the agency said in a press release.

Bamlanivimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19, the FDA said.

"The issuance of an EUA is different than FDA approval,"  the FDA said in a statement. "In determining whether to issue an EUA, the FDA evaluates the available evidence and carefully balances any known or potential risks with any known or potential benefits of the product for use during an emergency."

-ABC News' Eric Strauss

Dr. Anthony Fauci says he has no intention of leaving his post after President-elect Joe Biden assumes office.

The director of the National Institute of Allergy and Infectious Diseases declined to talk about the election during an interview with CNN Monday evening, but said he plans on staying in his position next year.

"I have no intention of leaving," he said. "This is an important job. I've been doing it now for a very long time. I've been doing it under six presidents. It's an important job and my goal is to serve the American public no matter what the administration is."

Fauci complimented the members of the new Biden/Harris COVID-19 task force, saying they're established colleagues that he admires and has worked with for years.

In the meantime, Fauci warned that Americans need to heed the health warnings and guidance in place as cases continue to rise across the country. Although Fauci called Pfizer's announcement of its vaccine progress "extraordinary," he said people need to remain cautious.

"This is something that we should really feel good about," he said of the vaccine news. "But I want to make sure people understand that it's good because we know there is light at the end of the tunnel, but that doesn't mean that we are going to give up the important public health measures that we continually still have to do every single day."

-ABC News' Stephanie Ebbs

U.S. President-elect Joe Biden and Vice President-elect Kamala Harris unveiled their transition COVID-19 advisory board on Monday morning, naming the people in charge of making the rubber of the duo’s coronavirus policy hit the road as they prepare to take office in just 72 days.

"Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts," Biden said in a statement announcing the board. "The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations."

In his first address to the nation as president-elect on Saturday night, Biden said one of his first actions would be putting the panel in place -- a signal of his primary focus on getting the coronavirus pandemic in check when he takes office in January.

As previously reported, the team will be led by three co-chairs: former Surgeon General Vivek Murthy and former Food and Drug Administration commissioner Dr. David Kessler, along with Dr. Marcella Nunez-Smith, a professor of medicine at Yale University.

In total, 13 co-chairs and members comprise the board, including former director of the Biomedical Advanced Research and Development Authority (BARDA), Dr. Rick Bright, who made headlines earlier this year when he resigned from his role at the National Institute of Health and filed a whistleblower complaint over "an abuse of authority or gross mismanagement" at the U.S. Department of Health and Human Services on the COVID-19 response.

Biden and Harris will receive a briefing from the board on Monday morning, according to their transition team -- the first public event for the pair since being projected as the winners of the 2020 election.

ABC News' Molly Nagle contributed to this report.